Patent | Date |
---|
Method of treating and preventing loss of cognition Grant 11,452,731 - Labrie September 27, 2 | 2022-09-27 |
Pharmaceutical Compositions App 20210069169 - LABRIE; Fernand | 2021-03-11 |
Pharmaceutical compositions Grant 10,881,650 - Labrie January 5, 2 | 2021-01-05 |
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM Grant 10,548,903 - Labrie , et al. Fe | 2020-02-04 |
Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of sexual dysfunction in postmenopausal women Grant 10,478,443 - El-Alfy , et al. Nov | 2019-11-19 |
A Method Of Treating And Preventing Loss Of Cognition App 20190269697 - LABRIE; Fernand | 2019-09-05 |
Method Of Preventing Alzheimier's Disease App 20190269696 - LABRIE; Fernand | 2019-09-05 |
Treatment of Alzheimer's disease, loss of cognition, memory loss and dementia with sex steroid precursors in combination with selective estrogen receptor modulators Grant 10,342,805 - Labrie July 9, 2 | 2019-07-09 |
Sex Steroid Precursors Alone Or In Combination With Selective Estrogen Receptor Modulators For The Prevention And Treatment Of Sexual Dysfunction In Postmenopausal Women App 20180271880 - EL-ALFY; Mohamed ;   et al. | 2018-09-27 |
Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of dyspareunia in postmenopausal women Grant 10,076,525 - El-Alfy , et al. September 18, 2 | 2018-09-18 |
Treatment Of Male Androgen Deficiency Symptoms Or Diseases With Sex Steroid Precursor Combined With Serm App 20170290847 - Labrie; Fernand ;   et al. | 2017-10-12 |
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM Grant 9,744,177 - Labrie , et al. August 29, 2 | 2017-08-29 |
Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety Grant 9,682,960 - Labrie , et al. June 20, 2 | 2017-06-20 |
17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators Grant 9,284,345 - Labrie , et al. March 15, 2 | 2016-03-15 |
Sex Steroid Precursors Alone Or In Combination With Selective Estrogen Receptor Modulators For The Prevention And Treatment Of Dyspareunia In Postmenopausal Women App 20160058774 - EL-ALFY; Mohamed ;   et al. | 2016-03-03 |
Helix 12 directed pharmaceutical products Grant 9,090,651 - Labrie , et al. July 28, 2 | 2015-07-28 |
Pharmaceutical compositions Grant 8,957,054 - Labrie February 17, 2 | 2015-02-17 |
Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women Grant 8,835,413 - El-Alfy , et al. September 16, 2 | 2014-09-16 |
Pharmaceutical compositions Grant 8,629,129 - Labrie January 14, 2 | 2014-01-14 |
Methods of treating and/or suppressing insulin resistance Grant 8,609,695 - Labrie , et al. December 17, 2 | 2013-12-17 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 8,389,548 - Labrie March 5, 2 | 2013-03-05 |
Pharmaceutical Compositions App 20130005700 - LABRIE; Fernand | 2013-01-03 |
Pharmaceutical Compositions App 20120322778 - LABRIE; Fernand | 2012-12-20 |
Pharmaceutical Compositions App 20120283230 - LABRIE; Fernand | 2012-11-08 |
Pharmaceutical compositions Grant 8,268,806 - Labrie September 18, 2 | 2012-09-18 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 8,188,066 - Labrie May 29, 2 | 2012-05-29 |
Helix 12 directed non-steroidal antiandrogens Grant 8,168,627 - Labrie , et al. May 1, 2 | 2012-05-01 |
Methods Of Treating Or Preventing Estrogen-related Diseases App 20110312925 - Labrie; Fernand | 2011-12-22 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 7,943,603 - Labrie May 17, 2 | 2011-05-17 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 7,884,092 - Labrie February 8, 2 | 2011-02-08 |
Treatment Of Hot Flushes, Vasomotor Symptoms, And Night Sweats With Sex Steroid Precursors In Combination With Selective Estrogen Receptor Modulators App 20100317635 - LABRIE; Fernand | 2010-12-16 |
Helix 12 Directed Non-steroidal Antiandrogens App 20100227855 - Labrie; Fernand ;   et al. | 2010-09-09 |
Helix 12 directed non-steroidal antiandrogens Grant 7,709,516 - Labrie , et al. May 4, 2 | 2010-05-04 |
Pharmaceutical compositions App 20090054383 - Labrie; Fernand | 2009-02-26 |
17alpha-substituted Steroids As Systemic Antiandrogens And Selective Androgen Receptor Modulators App 20090042844 - LABRIE; Fernand ;   et al. | 2009-02-12 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 7,429,576 - Labrie September 30, 2 | 2008-09-30 |
Pharmaceutical Compositions And Uses For Androst-5-ene-3beta, 17beta-diol App 20080161277 - Labrie; Fernand | 2008-07-03 |
Sex steroid precursor alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women App 20070270394 - El-Alfy; Mohamed ;   et al. | 2007-11-22 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors App 20070027124 - Labrie; Fernand | 2007-02-01 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors App 20070027123 - Labrie; Fernand | 2007-02-01 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors App 20070027122 - Labrie; Fernand | 2007-02-01 |
Use of androgens to reduce the likelihood of acquiring or to treat skin aging App 20060178352 - El-Alfy; Mohamed ;   et al. | 2006-08-10 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 7,005,428 - Labrie February 28, 2 | 2006-02-28 |
Pharmaceutical compositions and uses for androst-5-ene-3.beta., 17.beta.-diol Grant 6,995,150 - Labrie February 7, 2 | 2006-02-07 |
Pharmaceutical compositions and uses for androst-5-ene-3.beta., 17.beta.-diol Grant 6,964,955 - Labrie November 15, 2 | 2005-11-15 |
Helix 12 directed pharmaceutical products App 20050250749 - Labrie, Fernand ;   et al. | 2005-11-10 |
Antiandrogenic biphenyls Grant 6,933,321 - Labrie , et al. August 23, 2 | 2005-08-23 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors App 20050137178 - Labrie, Fernand | 2005-06-23 |
Pharmaceutical compositions and uses for androst-5-ene-3.beta., 17.beta.-diol Grant 6,884,795 - Labrie April 26, 2 | 2005-04-26 |
Topical antiandrogenic steroids App 20040224935 - Labrie, Fernand ;   et al. | 2004-11-11 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors App 20040157812 - Labrie, Fernand | 2004-08-12 |
Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use App 20040082556 - Labrie, Fernand ;   et al. | 2004-04-29 |
Methods of treating and/or suppressing weight gain Grant 6,710,059 - Labrie , et al. March 23, 2 | 2004-03-23 |
Methods of treating and/or suppressing insulin resistance App 20040034000 - Labrie, Fernand ;   et al. | 2004-02-19 |
Antiandrogenic biphenyls App 20040006134 - Labrie, Fernand ;   et al. | 2004-01-08 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 6,670,346 - Labrie December 30, 2 | 2003-12-30 |
Selective estrogen receptor modulators in combination with estrogens App 20030065008 - Labrie, Fernand | 2003-04-03 |
Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use Grant 6,541,463 - Labrie , et al. April 1, 2 | 2003-04-01 |
Selective estrogen receptor modulators in combination with estrogens App 20030040510 - Labrie, Fernand | 2003-02-27 |
Selective estrogen receptor modulators in combination with estrogens App 20020198179 - Labrie, Fernand | 2002-12-26 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL App 20020187968 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187973 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187966 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187963 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL App 20020187970 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187964 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187969 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187967 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187965 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol App 20020187962 - Labrie, Fernand | 2002-12-12 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors Grant 6,465,445 - Labrie October 15, 2 | 2002-10-15 |
Androgen derivatives for use in the inhibition of sex steroid activity Grant 6,110,906 - Labrie , et al. August 29, 2 | 2000-08-29 |
Benzopyran-containing compounds and method for their use Grant 6,060,503 - Labrie , et al. May 9, 2 | 2000-05-09 |
Therapeutic methods and delivery systems utilizing sex steroid precursors Grant 5,955,455 - Labrie September 21, 1 | 1999-09-21 |
Therapeutic methods and delivery systems utilizing sex steroid precursors Grant 5,948,434 - Labrie September 7, 1 | 1999-09-07 |
Therapeutic methods and delivery systems utilizing sex steroid precursors Grant 5,922,700 - Labrie July 13, 1 | 1999-07-13 |
Therapeutic methods and delivery systems utilizing sex steroid precursors Grant 5,872,114 - Labrie February 16, 1 | 1999-02-16 |
Controlled release systems and low dose androgens Grant 5,861,387 - Labrie , et al. January 19, 1 | 1999-01-19 |
Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds Grant 5,846,960 - Labrie December 8, 1 | 1998-12-08 |
Sex steroid activity inhibitors Grant 5,840,735 - Labrie , et al. November 24, 1 | 1998-11-24 |
Therapeutic methods and delivery systems utilizing sex steroid precursors Grant 5,837,700 - Labrie November 17, 1 | 1998-11-17 |
Therapeutic methods and delivery systems utilizing sex steroid precursors Grant 5,824,671 - Labrie October 20, 1 | 1998-10-20 |
Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia Grant 5,817,649 - Labrie October 6, 1 | 1998-10-06 |
Controlled release systems and low dose androgens Grant 5,814,340 - Labrie , et al. September 29, 1 | 1998-09-29 |
Therapeutic methods and delivery systems utilizing sex steroid precursors Grant 5,807,849 - Labrie September 15, 1 | 1998-09-15 |
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone Grant 5,776,923 - Labrie July 7, 1 | 1998-07-07 |
Low dose androgenic compounds for prevention and treatment of endometriosis Grant 5,753,639 - Labrie May 19, 1 | 1998-05-19 |
Sex steroid activity inhibitors Grant 5,686,465 - Labrie , et al. November 11, 1 | 1997-11-11 |
Estrogen nucleus derivatives for use in the inhibition of sex steroid activity Grant 5,686,437 - Labrie , et al. November 11, 1 | 1997-11-11 |
Controlled release systems and low dose androgens Grant 5,629,303 - Labrie , et al. May 13, 1 | 1997-05-13 |
Method of treatment of androgen-related diseases Grant 5,610,150 - Labrie March 11, 1 | 1997-03-11 |
Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia Grant 5,595,985 - Labrie January 21, 1 | 1997-01-21 |
Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds Grant 5,567,695 - Labrie October 22, 1 | 1996-10-22 |
Combination therapy for the treatment of estrogen-sensitive disease Grant 5,550,107 - Labrie August 27, 1 | 1996-08-27 |
Activation of androgen receptors with low dose non-masculinizing androgenic compounds Grant 5,545,634 - Labrie August 13, 1 | 1996-08-13 |
Controlled release systems and low dose androgens Grant 5,541,172 - Labrie , et al. July 30, 1 | 1996-07-30 |
Controlled release systems and low dose androgens Grant 5,434,146 - Labrie , et al. * July 18, 1 | 1995-07-18 |
Anti-estrogenic compounds and compositions Grant 5,395,842 - Labrie , et al. March 7, 1 | 1995-03-07 |
Therapeutic antiestrogens Grant 5,393,785 - Labrie , et al. February 28, 1 | 1995-02-28 |
Method of treatment of androgen-related diseases Grant 5,372,996 - Labrie December 13, 1 | 1994-12-13 |
Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds Grant 5,362,720 - Labrie November 8, 1 | 1994-11-08 |
Aromatase inhibitors Grant 5,227,375 - Labrie , et al. July 13, 1 | 1993-07-13 |
Estrogen nucleus derivatives for use in inhibition of sex steroid activity Grant 5,204,337 - Labrie , et al. April 20, 1 | 1993-04-20 |